Russell

@cheetos.bsky.social

Researching, writing, doodling (all views expressed are solely my own.)

We’re releasing a new series on the past, present & future of psychedelic conversion therapy. We examine its history in psychedelic research, influencers who pathologize queerness & what it means to welcome pro-conversion therapy advocates into a movement built around “healing.”

The crew discusses AtaiBeckley's acquisition by Eli Lilly, The Wall Street Journal's mini-documentary on 5-MeO-DMT, and a recent death that occurred during a psychedelic retreat. New episode out tomorrow on YouTube and all podcast apps.

"We are, in fact, leftists. We do think that we should spend a lot of effort & organization improving material conditions for humanity...[so] we have a better chance of having better trips individually & collectively when we open ourselves up in these chemical ways." @brianpace.bsky.social

Psymposia@psymposia.bsky.social · 2w ago

Check out @johnvibes.bsky.social interview with our team! We discuss a wide range of topics including the fallout of Lykos Therapeutics' MDMA trials, the tech bro and pharamceutical takeover of psychedelic culture, and MK-Ultra. www.youtube.com/watch?v=Iz1s...

We break down this viral paper in our recent interview with @tylerblack.bsky.social "What they're describing there with sweating, sleeping, hyperthermia...they're reporting a near miss death of serotonin syndrome, I suspect...and they're reporting their near miss as a success."

"Psychedelic Zealots" w/ Dr. Tyler Black

YouTube video by Psymposia

youtube.com

New Scientist@newscientist.com · last mo.

A woman with severe Alzheimer's disease who hadn't spoken more than single syllables in years began initiating conversation after a single dose of psilocybin

I helped write this response from SSDP to the Dear Colleague letters by SAMHSA last month. People who use drugs deserve more. Every pause in care carries risk and every barrier to harm reduction/treatment could be the difference of life or death. Give it a read here: ssdp.org/blog/samhsa-...

SAMHSA “Dear Colleague” Letters: Policy Shift Threatens Evidence-Based Drug Policy - SSDP

This blog post is a collaborative effort written by members of SSDP’s Science Policy and Harm Reduction Committees. For years, the Substance Abuse and Mental Health Services Administration (SAMHSA) ha...

ssdp.org

Psymposia developed a primer on the psychedelic industry for leftists in response to Donald Trump‘s April 18 Executive Order, which accelerates review of psychedelic drugs deemed “Breakthrough Therapies” and makes Schedule 1 drugs more accessible under Right to Try laws.

Just waking up to the right-wing influence in the psychedelic industry? Psymposia’s team has been reporting on this for 8 years. Check out our back catalogue to get up to speed.

In a new four-part series, we respond to the fire hose of misinformation about Psymposia that Hamilton Morris has been spouting for years. Episode 1 drops tomorrow on YouTube and podcasting apps!